720-777-0123
-
Conditions & Advice
Parenting Tips and Advice
From bringing home a new baby to building trust with your teen, our pediatric experts share guidance to help you navigate the ups and downs of parenthood.
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Marilyn Manco-Johnson, MD
- Hematology/Oncology - Pediatric
- Pediatrics
Get to know Marilyn Manco-Johnson, MD
- Blood Disorders
- Clotting Disorders
- Bleeding Disorders
- Pediatric Cancer
- English
My clinical interests are Coagulation, Hemophilia and Thrombosis, and Neonatal Hematology
Undergraduate 1972
Pennsylvania State University (PA)
Medical Education 1974
Jefferson Medical College of Thomas Jefferson University
Internship 1975
University of Colorado
Residency 1977
University of Colorado
Fellowship 1981
University of Colorado
For Patients:
I direct a wide variety of research studies designed to define optimal treatments for children with hemophilia and other bleeding disorders. My work on prophylactic use of clotting factor concentrates has revolutionized the treatment of children with severe hemophilia.
I direct a wide variety of research studies designed to define optimal treatments for children with hemophilia and other bleeding disorders. My work on prophylactic use of clotting factor concentrates has revolutionized the treatment of children with severe hemophilia.
For Referring Providers:
I am involved in clinical trials including thrombosis and hemostasis. I am interested in Neonatal Coagulation, Hemophilia, Von Willebrand’s Disease. I focus on prelicensure studies of novel clotting factors, as well as rare bleeding and clotting disorders, such as: Protein C deficiency and A/Hypo/Dysfibrinogenemia.
I am involved in clinical trials including thrombosis and hemostasis. I am interested in Neonatal Coagulation, Hemophilia, Von Willebrand’s Disease. I focus on prelicensure studies of novel clotting factors, as well as rare bleeding and clotting disorders, such as: Protein C deficiency and A/Hypo/Dysfibrinogenemia.
Researcher of the Year 2007
National Hemophilia Foundation
